Welcome to the 2026 UMBC–Stanford Workshop on Clinical Trials and Regulatory Science. We are delighted to bring together leaders from academia, regulatory agencies, the biopharmaceutical industry, and healthcare organizations for two days of scientific exchange, collaboration, and innovation.

As clinical research enters an era increasingly shaped by artificial intelligence, machine learning, and real-world evidence, the need for rigorous statistical methods and sound regulatory decision-making has never been greater. This year's theme, "From Statistical Rigor to AI-enabled Decision-making," highlights the evolving landscape of clinical trials and the opportunities created by emerging technologies to improve drug development, regulatory evaluation, and patient outcomes.

The workshop provides a unique forum for researchers, statisticians, clinicians, data scientists, regulatory professionals, and industry experts to share knowledge, discuss challenges, and explore innovative solutions in clinical trial design, biostatistics, regulatory science, and AI-driven healthcare research.

Participants will benefit from keynote presentations, expert panel discussions, educational short courses, poster sessions, and networking opportunities designed to foster interdisciplinary collaboration and advance the future of biomedical innovation.

We sincerely thank our speakers, sponsors, supporting organizations, and attendees for their contributions to this important event. We look forward to welcoming you to the UMBC campus and to engaging in meaningful discussions that will help shape the future of clinical trials and regulatory science.